Skip to main content
Top
Published in: Diabetologia 1/2016

01-01-2016 | Short Communication

Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries

Authors: Jennifer L. Sherr, Julia M. Hermann, Fiona Campbell, Nicole C. Foster, Sabine E. Hofer, Jeremy Allgrove, David M. Maahs, Thomas M. Kapellen, Naomi Holman, William V. Tamborlane, Reinhard W. Holl, Roy W. Beck, Justin T. Warner, for the T1D Exchange Clinic Network, the DPV Initiative, and the National Paediatric Diabetes Audit and the Royal College of Paediatrics and Child Health registries

Published in: Diabetologia | Issue 1/2016

Login to get access

Abstract

Aims/hypothesis

While the use of insulin pumps in paediatrics has expanded dramatically, there is still considerable variability among countries in the use of pump technology. The present study sought to describe differences in metabolic control and pump use in young people with type 1 diabetes using data collected in three multicentre registries.

Methods

Data for the years 2011 and 2012 from 54,410 children and adolescents were collected from the Prospective Diabetes Follow-up Registry (DPV; n = 26,198), T1D Exchange (T1DX; n = 13,755) and the National Paediatric Diabetes Audit (NPDA; n = 14,457). The modality of insulin delivery, based on age, sex and ethnic minority status, and the impact of pump use on HbA1c levels were compared.

Results

The overall mean HbA1c level was higher in the NPDA (8.9 ± 1.6% [74 ± 17.5 mmol/mol]) than in the DPV (8.0 ± 1.6% [64 ± 17.0 mmol/mol], p < 0.001) and T1DX (8.3 ± 1.4% [68 ± 15.4 mmol/mol], p < 0.001). Conversely, pump use was much lower in the NPDA (14%) than in the DPV (41%, p < 0.001) and T1DX (47%, p < 0.001). In a pooled analysis, pump use was associated with a lower mean HbA1c (pump: 8.0 ± 1.2% [64 ± 13.3 mmol/mol] vs injection: 8.5 ± 1.7% [69 ± 18.7 mmol/mol], p < 0.001). In all three registries, those with an ethnic minority status were less likely to be treated with a pump (p < 0.001) and boys were treated with a pump less often compared with girls (p < 0.001).

Conclusions/interpretation

Despite similar clinical characteristics and proportion of minority participants, substantial differences in metabolic control exist across the three large transatlantic registries of paediatric patients with type 1 diabetes, which appears to be due in part to the frequency of insulin pump therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300:573–578CrossRefPubMed Tamborlane WV, Sherwin RS, Genel M, Felig P (1979) Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 300:573–578CrossRefPubMed
2.
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
3.
go back to reference Sherr J, Cengiz E, Tamborlane WV (2009) From pumps to prevention: recent advances in the treatment of type 1 diabetes. Drug Discov Today 14:973–981CrossRefPubMed Sherr J, Cengiz E, Tamborlane WV (2009) From pumps to prevention: recent advances in the treatment of type 1 diabetes. Drug Discov Today 14:973–981CrossRefPubMed
4.
go back to reference Johnson SR, Cooper MN, Jones TW, Davis EA (2013) Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia 56:2392–2400CrossRefPubMed Johnson SR, Cooper MN, Jones TW, Davis EA (2013) Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia 56:2392–2400CrossRefPubMed
5.
go back to reference Phillip M, Battelino T, Rodriguez H et al (2007) Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30:1653–1662CrossRefPubMed Phillip M, Battelino T, Rodriguez H et al (2007) Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 30:1653–1662CrossRefPubMed
6.
go back to reference Maahs DM, Hermann JM, Holman N et al (2015) Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care 38:1876–1882CrossRefPubMed Maahs DM, Hermann JM, Holman N et al (2015) Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care 38:1876–1882CrossRefPubMed
7.
go back to reference The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177–188CrossRef The Diabetes Control and Complications Trial Research Group (1994) Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 125:177–188CrossRef
8.
go back to reference Rewers MJ, Pillay K, de Beaufort C et al (2014) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):102–114CrossRefPubMed Rewers MJ, Pillay K, de Beaufort C et al (2014) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 15(Suppl 20):102–114CrossRefPubMed
9.
go back to reference Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors (2014) Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37:2034–2054CrossRefPubMed Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors (2014) Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 37:2034–2054CrossRefPubMed
Metadata
Title
Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries
Authors
Jennifer L. Sherr
Julia M. Hermann
Fiona Campbell
Nicole C. Foster
Sabine E. Hofer
Jeremy Allgrove
David M. Maahs
Thomas M. Kapellen
Naomi Holman
William V. Tamborlane
Reinhard W. Holl
Roy W. Beck
Justin T. Warner
for the T1D Exchange Clinic Network, the DPV Initiative, and the National Paediatric Diabetes Audit and the Royal College of Paediatrics and Child Health registries
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3790-6

Other articles of this Issue 1/2016

Diabetologia 1/2016 Go to the issue